Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)
CUSIP: 51654W101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 11,280,432
- Total 13F shares
- 82,988
- Share change
- -87,139
- Total reported value
- $1,597,009
- Price per share
- $19.24
- Number of holders
- 10
- Value change
- -$1,643,167
- Number of buys
- 5
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 51654W101:
Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ZEKE CAPITAL ADVISORS, LLC |
13F
|
Company |
0.75%
|
84,750
|
$1,597,000 | — | 30 Sep 2020 | |
| Voss Capital, LP |
13F
|
Company |
0.31%
|
35,067
|
$661,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
21,384
|
$403,000 | — | 30 Sep 2020 | |
| Rock Creek Group, LP |
13F
|
Company |
0.1%
|
11,306
|
$213,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
5,009
|
$94,000 | — | 30 Sep 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,000
|
$19,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
709
|
$13,000 | — | 30 Sep 2020 | |
| CHIRON CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
500
|
$9,000 | — | 30 Sep 2020 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
200
|
$4,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
112
|
$2,000 | — | 30 Sep 2020 | |
| FinTrust Capital Advisors, LLC |
13F
|
Company |
0%
|
90
|
$2,000 | — | 30 Sep 2020 |
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q4 2020
As of 31 Dec 2020,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,988 shares.
The largest 10 holders included
MORGAN STANLEY, Voss Capital, LLC, Rock Creek Group, LP, CM Management, LLC, BlackRock Inc., ROYAL BANK OF CANADA, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, Tower Research Capital LLC (TRC), Mesirow Financial Investment Management, Inc., and WELLS FARGO & COMPANY/MN.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
11
Q4 2020 holders
10
Holder diff
-1
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.